Patents at the Supreme Court: Update and Fallout

Warren Woessner and Charles R. Macedo will speak on patentable subject matter post-Myriad, Prometheus and CLS in the upcoming AUTM Webinar on September 12.  Warren (Schwegman Lundberg) will present on the patentability of life sciences’ inventions such as diagnostics, drug regimens and “genes” while Charles (Amster Rothstein) will cover software, business methods and computer science, as interpreted in recent decisions by the Supreme Court and the Federal Circuit.  For registration info, click here.

Posted in Patent Eligible Subject Matter, Webinar | Tagged , , , , , , , | Leave a comment

Review of Indian Working Requirements

This newsletter (attached below) from a leading Indian firm, contains a good review of the perils of the working requirement in India. It also provides a good summary of three recent decisions holding pharma patents invalid for obviousness. What is striking is that the judicial hostility in India to “add-on” drug patents now seems reflected in recent Fed. Cir. opinions that are “anti-patent,” at least as considered by the innovator companies.

IPR_Amicus_August_2013

Posted in Int'l Practice and Policy | Tagged , , , , , , , , | Leave a comment

Hamilton Beach v. Sunbeam Products – “On Sale” Bar Clarified

On Wednesday August 14th, a divided  Fed. Cir. panel affirmed the invalidation of Hamilton Beach’s portable slow cooker under the “on-sale” or “in public use” bars of s. 102(b). Hamilton Beach Brands v. Sunbeam Prods., Inc., Appeal No. 2012-1581 (Fed. Cir. Aug. 14, 2013). (A copy of the decision is available at the end of this post.) Hamilton Beach had ordered 2000 of the cookers from an overseas’ supplier prior to the critical date (one year prior to the effective filing date of the application that claimed the purchased version of the cooker). The majority found that the offer to sell made by the supplier activated the on-sale bar of 102(b), and that the hoary “experimental use” exception does not apply since the cookers were ready for patenting. The dissenting member of the panel felt that the experimental use exception should apply since the sale did not meet the standards for a “commercial sale.”

Interesting, as noted by at least one commentator, under AIA’s 102(b) exception to the on-sale bar of 102(a)(1), if the disclosure (the sale) had been made within a year of filing, the exception would apply, since the seller obtained the subject matter directly from the inventors, via Sunbeam.  However, the purchase would still be a bar if it fell outside the grace period.

I know that this is not anything like a big change in biotech/pharma patent law, but it is a very good review of the on sale bar and the experimental use exception to the bar.

12-1581.Opinion.8-12-2013.1.PDF0_C

Posted in 102 Patentability | Tagged , , , , , , , , | Leave a comment

Submission of Copyrighted Articles to the PTO “Fair Use”, D. Minn. Magistrate Rules

Federal Magistrate Jeffrey Keyes ruled that it is fair use for law firms to use copyrighted journal articles when preparing patent applications, and recommended that an infringement suit against Schwegman Lundberg & Woessner PA (SLW) by two academic publishers be dismissed.

Brad Forrest, SLW shareholder and chairman said:

“We are pleased with the result.  The decision supports the long standing practice of providing patent offices with non-patent literature to help improve patent quality.  It benefits every inventor and company involved in innovation, without harming established markets for copyrighted works.”

More information about the ruling can be found on Law360’s site.

Posted in About SLW | Tagged , , , , , | Leave a comment